{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T02:06:23Z","timestamp":1790129183789,"version":"4.0.1"},"reference-count":33,"publisher":"Public Library of Science (PLoS)","issue":"6","license":[{"start":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T00:00:00Z","timestamp":1782777600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"<jats:sec id=\"sec001\">\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Hemoadsorption is considered currently as an adjunct therapy for the treatment of rhabdomyolysis and acute kidney injury (AKI) although the exact timing is not yet determined. We hypothesised that earlier start of hemoadsorption in patients with ischemia\/reperfusion caused rhabdomyolysis and AKI leads to a better clinical improvement and recovery of kidney function.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec002\">\n                    <jats:title>Materials and methods<\/jats:title>\n                    <jats:p>We conducted a single-center, retrospective cohort study. Treatment was defined as the use of hemoadsorption with CytoSorb\u00ae in combination with continuous renal replacement therapy (CRRT) compared to patients who were treated only with CRRT. Patients were divided in early and late initiation of hemoadsorption subgroups by less or more than 12 hours after developing acute kidney injury. Myoglobin and creatine kinase plasma levels were measured shortly before, 12 hours after the start of treatment, and 24, 48, and 72 hours after initiation. The follow-up lasted until the last enrolled patient reached 60 days after first hemoadsorption procedure.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec003\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Overall, 30 patients were included in the treatment arm and 25 patients in the control group. Significant decrease of myoglobin levels was observed in the hemoadsorption treated group in all time points when compared with the control group. Logistical regression analysis found the association of hemoadsorption use and shorter duration of AKI (OR 3.46) and less acute kidney disease (AKD) (OR 2.85). Earlier start of hemoadsorption was associated with a statistically significant shorter duration of AKI (OR 3.22) and less AKD (OR 3.10). Patients treated early with hemoadsorption survived significantly longer than patients treated late (49.2 vs 15.3 days; p\u2009&lt;\u20090.001).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec004\">\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Early start of combined CRRT and hemoadsorption therapy with CytoSorb was safe and associated with improved kidney recovery and survival in patients with ischemic\/reperfusion rhabdomyolysis and AKI. Early start of hemoadsorption might prevent renal failure and acute kidney disease and shorten the CRRT dependency in patients who develop AKI.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1371\/journal.pone.0352417","type":"journal-article","created":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T19:07:05Z","timestamp":1782846425000},"page":"e0352417","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":1,"title":["Early start of hemoadsorption is associated with improved kidney recovery in ICU patients with ischemic\/reperfusion cause of rhabdomyolysis"],"prefix":"10.1371","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6264-6809","authenticated-orcid":true,"given":"Vedran","family":"Premuzic","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan","family":"Horvat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mate","family":"Mogus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7469-2968","authenticated-orcid":true,"given":"Ivona","family":"Vucic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivan","family":"Situm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2470-6238","authenticated-orcid":true,"given":"Tina","family":"Tomic-Mahecic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeljko","family":"Colak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirabel","family":"Mazar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Baronica","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Slobodan","family":"Mihaljevic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2026,6,30]]},"reference":[{"issue":"4","key":"pone.0352417.ref001","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1007\/s00540-020-02792-w","article-title":"A \u201ccrush\u201d course on rhabdomyolysis: risk stratification and clinical management update for the perioperative clinician","volume":"34","author":"DR Cote","year":"2020","journal-title":"J Anesth"},{"issue":"1","key":"pone.0352417.ref002","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1056\/NEJMra0801327","article-title":"Rhabdomyolysis and acute kidney injury","volume":"361","author":"X Bosch","year":"2009","journal-title":"N Engl J Med"},{"issue":"6","key":"pone.0352417.ref003","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1515\/CCLM.2010.151","article-title":"Rhabdomyolysis: historical background, clinical, diagnostic and therapeutic features","volume":"48","author":"G Cervellin","year":"2010","journal-title":"Clin Chem Lab Med"},{"issue":"1","key":"pone.0352417.ref004","first-page":"58","article-title":"Rhabdomyolysis: pathogenesis, diagnosis, and treatment","volume":"15","author":"PA Torres","year":"2015","journal-title":"Ochsner J"},{"issue":"6","key":"pone.0352417.ref005","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1111\/j.1399-6576.2005.00577.x","article-title":"Prognostic value, kinetics and effect of CVVHDF on serum of the myoglobin and creatine kinase in critically ill patients with rhabdomyolysis","volume":"49","author":"TS Mikkelsen","year":"2005","journal-title":"Acta Anaesthesiol Scand"},{"issue":"6","key":"pone.0352417.ref006","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1159\/000494337","article-title":"Rhabdomyolysis among Critically Ill Combat Casualties: Long-Term Outcomes","volume":"48","author":"T Faulk","year":"2018","journal-title":"Am J Nephrol"},{"issue":"1","key":"pone.0352417.ref007","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1186\/s13054-020-03366-8","article-title":"Myoglobin clearance with continuous veno-venous hemodialysis using high cutoff dialyzer versus continuous veno-venous hemodiafiltration using high-flux dialyzer: a prospective randomized controlled trial","volume":"24","author":"L Weidhase","year":"2020","journal-title":"Crit Care"},{"issue":"2","key":"pone.0352417.ref008","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1186\/cc3055","article-title":"Extracorporeal therapies in acute rhabdomyolysis and myoglobin clearance","volume":"9","author":"C Ronco","year":"2005","journal-title":"Crit Care"},{"issue":"4","key":"pone.0352417.ref009","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1177\/17511437211050782","article-title":"Rhabdomyolysis: An evidence-based approach","volume":"23","author":"S Burgess","year":"2022","journal-title":"J Intensive Care Soc"},{"issue":"2","key":"pone.0352417.ref010","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1007\/s00134-018-5464-6","article-title":"Hemoadsorption with CytoSorb\u00ae","volume":"45","author":"EC Poli","year":"2019","journal-title":"Intensive Care Med"},{"issue":"11","key":"pone.0352417.ref011","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1007\/s13312-019-1661-9","article-title":"Cytosorb for Management of Acute Kidney Injury due to Rhabdomyolysis in a Child","volume":"56","author":"S Padiyar","year":"2019","journal-title":"Indian Pediatr"},{"issue":"6","key":"pone.0352417.ref012","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1159\/000505899","article-title":"Successful Reduction of Creatine Kinase and Myoglobin Levels in Severe Rhabdomyolysis Using Extracorporeal Blood Purification (CytoSorb\u00ae)","volume":"49","author":"O Dilken","year":"2020","journal-title":"Blood Purif"},{"issue":"2","key":"pone.0352417.ref013","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1159\/000534479","article-title":"Rapid and Effective Elimination of Myoglobin with CytoSorb\u00ae Hemoadsorber in Patients with Severe Rhabdomyolysis","volume":"53","author":"F Albrecht","year":"2024","journal-title":"Blood Purif"},{"issue":"1","key":"pone.0352417.ref014","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s13054-021-03468-x","article-title":"Blood purification with a cytokine adsorber for the elimination of myoglobin in critically ill patients with severe rhabdomyolysis","volume":"25","author":"C Scharf","year":"2021","journal-title":"Crit Care"},{"issue":"1","key":"pone.0352417.ref015","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1186\/s13054-023-04492-9","article-title":"Efficacy of CytoSorb\u00ae: a systematic review and meta-analysis","volume":"27","author":"S Becker","year":"2023","journal-title":"Crit Care"},{"key":"pone.0352417.ref016","doi-asserted-by":"crossref","first-page":"801807","DOI":"10.3389\/fped.2021.801807","article-title":"Case Report: Prevention of Rhabdomyolysis-Associated Acute Kidney Injury by Extracorporeal Blood Purification With Cytosorb\u00ae","volume":"9","author":"S Rauch","year":"2022","journal-title":"Front Pediatr"},{"issue":"1","key":"pone.0352417.ref017","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1186\/s12882-024-03679-8","article-title":"Hemoadsorption therapy for myoglobin removal in rhabdomyolysis: consensus of the hemoadsorption in rhabdomyolysis task force","volume":"25","author":"L Forni","year":"2024","journal-title":"BMC Nephrol"},{"issue":"1","key":"pone.0352417.ref018","doi-asserted-by":"crossref","first-page":"2600720","DOI":"10.1080\/0886022X.2025.2600720","article-title":"Hemoadsorption therapy in severe rhabdomyolysis: a report from the international, prospective COSMOS (CytOSorb\u00ae TreatMent of Critically ill PatientS) registry","volume":"47","author":"R Ferrer","year":"2025","journal-title":"Ren Fail"},{"issue":"1","key":"pone.0352417.ref019","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1186\/s13054-024-05220-7","article-title":"Use of extracorporeal blood purification therapies in sepsis: the current paradigm, available evidence, and future perspectives","volume":"28","author":"G Bottari","year":"2024","journal-title":"Crit Care"},{"issue":"1","key":"pone.0352417.ref020","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/s13054-017-1662-9","article-title":"Hemoadsorption by CytoSorb in septic patients: a case series","volume":"21","author":"K Kogelmann","year":"2017","journal-title":"Crit Care"},{"issue":"3","key":"pone.0352417.ref021","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1038\/ki.2013.243","article-title":"Comments on \u201cKDIGO 2012 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease\u201d","volume":"84","author":"KM Andrassy","year":"2013","journal-title":"Kidney Int"},{"issue":"13","key":"pone.0352417.ref022","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1001\/jama.2019.14745","article-title":"Chronic Kidney Disease Diagnosis and Management: A Review","volume":"322","author":"TK Chen","year":"2019","journal-title":"JAMA"},{"key":"pone.0352417.ref023","first-page":"1","article-title":"Kidney disease improving global outcomes (KDIGO) clinical practice guideline for acute kidney injury","volume":"2","author":"Kidney Disease Improving Global Outcomes (KDIGO)","year":"2012","journal-title":"Kidney Int Suppl"},{"key":"pone.0352417.ref024","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1038\/nrneph.2017.2","article-title":"Acute kidney disease and renal recovery: consensus report of the Acute Disease Quality Initiative (ADQI) 16 Workgroup","volume":"13","author":"L Chawla","year":"2017","journal-title":"Nat Rev Nephrol"},{"issue":"1","key":"pone.0352417.ref025","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1186\/s13613-024-01334-x","article-title":"Myoglobin adsorption and saturation kinetics of the cytokine adsorber Cytosorb\u00ae in patients with severe rhabdomyolysis: a prospective trial","volume":"14","author":"H Graf","year":"2024","journal-title":"Ann Intensive Care"},{"issue":"2","key":"pone.0352417.ref026","doi-asserted-by":"crossref","DOI":"10.1093\/ckj\/sfae406","article-title":"Efficacy of haemoadsorption combined with continuous renal replacement therapy in patients with rhabdomyolysis and acute kidney injury: a retrospective study","volume":"18","author":"X Zhou","year":"2024","journal-title":"Clin Kidney J"},{"issue":"5","key":"pone.0352417.ref027","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1159\/000528861","article-title":"Clearance of NT-proBNP and Procalcitonin during Continuous Venovenous Hemodialysis with the Medium Cutoff Filter in Patients with Rhabdomyolysis-Associated Early Acute Kidney Injury","volume":"52","author":"F Mariano","year":"2023","journal-title":"Blood Purif"},{"issue":"10","key":"pone.0352417.ref028","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1177\/03913988241269508","article-title":"How I treat rhabdomyolysis-induced AKI? A different perspective","volume":"47","author":"G Bottari","year":"2024","journal-title":"Int J Artif Organs"},{"issue":"23","key":"pone.0352417.ref029","doi-asserted-by":"crossref","first-page":"7199","DOI":"10.3390\/jcm12237199","article-title":"Adjunctive Hemoadsorption Therapy with CytoSorb in Patients with Septic\/Vasoplegic Shock: A Best Practice Consensus Statement","volume":"12","author":"S Mitzner","year":"2023","journal-title":"J Clin Med"},{"issue":"6","key":"pone.0352417.ref030","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1002\/mus.24606","article-title":"Diagnostic evaluation of rhabdomyolysis","volume":"51","author":"JR Nance","year":"2015","journal-title":"Muscle Nerve"},{"key":"pone.0352417.ref031","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1053\/j.semvascsurg.2015.01.007","article-title":"Biochemical markers of acute limb ischemia, rhabdomyolysis, and impact on limb salvage","volume":"27","author":"JDB Watson","year":"2014","journal-title":"Semin Vasc Surg"},{"issue":"2","key":"pone.0352417.ref032","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.surg.2023.04.033","article-title":"Severe muscle damage after a short period of ischemia and reperfusion in an animal model","volume":"174","author":"EG de Carvalho","year":"2023","journal-title":"Surgery"},{"issue":"4","key":"pone.0352417.ref033","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.jvs.2003.11.038","article-title":"Influence of renal insufficiency on limb loss and mortality after initial lower extremity surgical revascularization","volume":"39","author":"AM O\u2019Hare","year":"2004","journal-title":"J Vasc Surg"}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0352417","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T19:07:10Z","timestamp":1782846430000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0352417"}},"subtitle":[],"editor":[{"given":"Jaspinder","family":"Kaur","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2026,6,30]]},"references-count":33,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2026,6,30]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0352417","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,30]]}}}